$AGIO News Article - Agios Presents Updated Data f
Post# of 83
(Total Views: 263)
Posted On: 06/03/2019 1:55:43 PM
$AGIO News Article - Agios Presents Updated Data from Phase 1 Studies of TIBSOVO (ivosidenib) in Newly Diagnosed Adult Patients with IDH1 Mutant Acute Myeloid Leukemia (AML) Not Eligible for Intensive Chemotherapy https://marketwirenews.com/news-releases/agio...88982.html
(0)
(0)Agios Pharmaceuticals Inc. (AGIO) Stock Research Links
My Twitter: WhyteStocks
Scroll down for more posts ▼